NeuroOne
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.9m | <1m | <1m | 2.0m | 7.0m | 13.3m | 15.2m |
% growth | 1025 % | (91 %) | (4 %) | 1041 % | 259 % | 90 % | 14 % |
EBITDA | (4.9m) | (9.9m) | (9.9m) | (12.0m) | (13.4m) | (13.5m) | (9.3m) |
% EBITDA margin | (252 %) | (5538 %) | (5773 %) | (612 %) | (191 %) | (102 %) | (61 %) |
Profit | (13.6m) | (9.9m) | (10.0m) | (11.9m) | (13.6m) | (13.6m) | (9.4m) |
% profit margin | (708 %) | (5584 %) | (5842 %) | (607 %) | (194 %) | (102 %) | (62 %) |
EV / revenue | 13.4x | 229.1x | 96.2x | 8.3x | 4.5x | 2.3x | 2.0x |
EV / EBITDA | -5.3x | -4.1x | -1.7x | -1.4x | -2.3x | -2.3x | -3.4x |
R&D budget | 2.1m | 3.9m | 4.9m | 6.9m | - | - | - |
R&D % of revenue | 108 % | 2203 % | 2880 % | 355 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $700k | Early VC | |
N/A | $825k | Early VC | |
N/A | N/A | IPO | |
$7.0m | Post IPO Equity | ||
Total Funding | €1.4m |
Related Content
Recent News about NeuroOne
EditNeuroOne Medical Technologies Company specializes in developing high definition, minimally invasive diagnostic and therapeutic devices based on their proprietary thin film electrode technology. The company focuses on creating advanced solutions for recording, stimulation, and ablation to treat neurological disorders affecting the brain, spine, and other areas. NeuroOne's primary market includes patients suffering from epilepsy and those in need of neurostimulation devices, a rapidly growing sector. Their business model revolves around the development and commercialization of patented electrode designs that offer higher resolution recordings of neuron activity, thereby enhancing the precision and effectiveness of neurosurgical applications. Revenue is generated through the sale of these innovative medical devices to healthcare providers and institutions.
Keywords: thin film electrodes, high definition, minimally invasive, neurological diagnostics, neurostimulation, epilepsy treatment, neuron activity recording, neurosurgical applications, medical devices, patented technology.